Corvus Pharmaceuticals, Inc.
← Back to CRVS Overview

Corvus Pharmaceuticals, Inc. (CRVS)

Price-to-Earnings Ratio History

P/E Ratio (TTM)

-12.34

Financial Fundamentals

CRVSQuarterly Data • 5Y View

Quarterly P/E

QuarterP/E Ratio
2014-12-31-7.24
2015-03-31-16.56
2015-06-30-3.59
2015-09-30-23.07
2015-12-31-5.25
2016-03-31-0.67
2016-06-30-8.23
2016-09-30-8.06
2016-12-31-6.53
2017-03-31-6.59
2017-06-30-4.12
2017-09-30-6.42
2017-12-31-4.49
2018-03-31-4.55
2018-06-30-6.84
2018-09-30-5.69
2018-12-31-2.55
2019-03-31-2.52
2019-06-30-2.34
2019-09-30-2.01
2019-12-31-3.62
2020-03-31-1.20
2020-06-30-1.89
2020-09-30-3.02
2020-12-310.96
2021-03-31-2.30
2021-06-30-2.40
2021-09-30-4.98
2021-12-31-3.04
2022-03-31-2.30
2022-06-30-1.38
2022-09-30-0.64
2022-12-31-1.01
2023-03-31-1.35
2023-06-30-4.18
2023-09-30-2.98
2023-12-31-3.24
2024-03-31-4.00
2024-06-30-6.48
2024-09-30-2.19
2024-12-31-7.55
2025-03-313.77
2025-06-30-9.72
2025-09-30-15.03
2025-12-31-12.34

* P/E ratios are calculated using trailing twelve-month (TTM) earnings.